REG - IXICO plc - Director and PDMR share purchase

IXICOAnnouncement

11/07/2019 07:05

RNS Number : 1541F
IXICO plc
11 July 2019
 


11 July 2019
 
IXICO plc
("IXICO" or the "Company")
 
Director and PDMR share purchase
IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that it received notification on 10 July 2019 that on 05 July 2019 and 09 July 2019 Charles Spicer, Chairman of the Company, acquired 140,421 ordinary shares at an average price of 28.485p.
 
Charles Spicer is interested in 333,196 Ordinary Shares, representing 0.71 per cent of the enlarged issued share capital of the Company following the purchase.
 



1
 


Details of the person discharging managerial responsibilities / person closely associated
 




a)
 


Name
 
 


Charles Spicer
 




2
 


Reason for the notification
 




a)
 


Position/status
 
 


Chairman




b)
 


Initial notification /Amendment
 
 


Initial notification




3
 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 




a)
 


Name
 
 


IXICO plc




b)
 


LEI
 
 


2138005M1F59O6HWSA97




4
 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 
 




a)
 


Description of the financial instrument, type of instrument


Ordinary Shares in IXICO plc














Identification code


GB00BCLY7L40




 








b)
 


Nature of the transaction
 
 


Acquisition




c)
 


Price(s) and volume(s)


 


 


 


 








 


Price(s)


Volume(s)


 








 


5/7/19


 


 








 


29.499p


33,899


 








 


29p


34,482


 








 


29p


34,482


 








 


9/7/19


 


 








 


26.625p


37,558


 








 


 


 


 




d)
 


Aggregated information


















- Aggregated volume


140,421 shares














- Price


28.485p














e)
 


Date of the transaction
 
 


5/7/19 and 9/7/19




f)
 


Place of the transaction
 
 


London Stock Exchange, AIM Market (IXI), UK



 



IXICO plc


+44 (0) 20 3763 7498




Giulio Cerroni, Chief Executive Officer


















Cenkos Securities PLC (Nominated adviser and sole broker)


+44 (0) 20 7397 8900




Giles Balleny / Max Gould (Corporate Finance)








Michael F Johnson / Russell Kerr (Sales)


















Optimum Strategic Communications


 +44 (0) 203 950 9144




Mary Clark / Anne Marieke Ezendam / Supriya Mathur








ixico@optimumcomms.com







 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHURVNRKOABAAR